Robertet SA Cert.d'Invest. Em.87 (CBE) AI Stock Analysis

• Market Cap: €1.61B
• Dividend Yield: 1.36%
• Average Volume (3M): 16.00
• Price to Earnings (P/E): 15.4
• Beta (1Y): 0.22
• Revenue Growth: 10.55%
• EPS Growth: 13.50%
• Country: FR
• Employees: 2,587
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 27.90
• Shares Outstanding: 122,792
• 10 Day Avg. Volume: 23
• 30 Day Avg. Volume: 16
• PEG Ratio: 0.96
• Price to Book (P/B): 3.21
• Price to Sales (P/S): 2.20
• P/FCF Ratio: 24.03
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: €812.00 ▲(12.78% Upside)

Robertet SA's strong financial performance is the most significant factor, supported by robust revenue growth and efficient cost management. The technical analysis indicates a stable trend but with potential bearish momentum. The valuation is reasonable, making the stock attractive for both growth and income-focused investors. The absence of earnings call and corporate events data did not impact the score.

Robertet SA Cert.d'Invest. Em.87 Business Overview & Revenue Model

Company Description

Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.

How the Company Makes Money

The company generates revenue primarily through the sale of its natural fragrance and flavor products to various industries, including cosmetics, food and beverage, and household goods manufacturers. Key revenue streams include customized formulations, essential oils, and flavoring agents, which are sold to clients on a wholesale basis. Additionally, Robertet SA benefits from long-term partnerships with major brands in the fragrance and food sectors, allowing for steady demand and recurring sales. The company's focus on research and development also enables it to introduce new products that cater to evolving consumer preferences, thereby enhancing its market position and revenue potential.

Robertet SA Cert.d'Invest. Em.87 Financial Statement Overview

Summary

Robertet SA exhibits strong financial health with robust revenue growth, efficient cost management, and solid cash flow generation. The balance sheet is well-capitalized, though the increase in debt levels warrants careful monitoring. With continued focus on improving net margins and managing leverage, the company is well-positioned for sustainable growth.

Income Statement

Robertet SA has demonstrated a healthy growth in total revenue, with a significant increase from €721 million in 2023 to €808 million in 2024, marking a revenue growth rate of approximately 12%. The gross profit margin is strong, reflecting efficient production and cost management. EBIT and EBITDA margins are solid, indicating robust operational efficiency. However, the net profit margin could be improved, suggesting potential areas for cost optimization.

Balance Sheet

The company maintains a healthy equity ratio, highlighting strong capitalization with stockholders' equity making up 55% of total assets. The debt-to-equity ratio is moderate, indicating manageable leverage levels. However, there has been an increase in total debt from 2023 to 2024, which could pose risks if not carefully managed. Return on equity remains satisfactory, reflecting effective utilization of shareholder funds.

Cash Flow

Operating cash flow has increased from €102 million in 2023 to €112 million in 2024, demonstrating strong cash-generating capability. The free cash flow is positive and stable, though there was a slight decline from the previous year. This suggests effective capital expenditure management, although further improvements could enhance cash flow consistency.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	839.37M	807.61M	721.13M	703.04M	606.09M	538.32M
Gross Profit	143.39M	455.19M	391.79M	373.36M	101.89M	82.08M
EBITDA	169.87M	160.03M	132.89M	125.61M	115.44M	89.50M
Net Income	96.88M	90.07M	74.60M	76.02M	71.71M	50.58M
Balance Sheet
Total Assets	1.01B	1.01B	927.13M	847.21M	783.29M	669.71M
Cash, Cash Equivalents and Short-Term Investments	164.99M	193.47M	172.59M	128.06M	190.01M	150.85M
Total Debt	286.10M	268.00M	325.63M	297.87M	112.73M	87.27M
Total Liabilities	450.06M	456.07M	460.72M	431.43M	237.39M	193.41M
Stockholders Equity	557.44M	551.80M	465.51M	414.99M	545.73M	476.26M
Cash Flow
Free Cash Flow	59.18M	73.82M	84.47M	24.11M	64.34M	86.24M
Operating Cash Flow	99.06M	112.41M	101.82M	46.87M	85.12M	101.07M
Investing Cash Flow	-38.91M	-38.33M	-81.21M	-67.36M	-45.83M	-22.97M
Financing Cash Flow	-64.11M	-58.93M	-2.30M	-43.28M	-4.69M	-22.03M

Robertet SA Cert.d'Invest. Em.87 Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 720.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CBE, the sentiment is Positive. The current price of 720 is above the 20-day moving average (MA) of 717.08, above the 50-day MA of 712.38, and below the 200-day MA of 722.19, indicating a bullish trend. The MACD of 3.64 indicates Negative momentum. The RSI at 67.75 is Neutral, neither overbought nor oversold. The STOCH value of 92.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:CBE.

Robertet SA Cert.d'Invest. Em.87 Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALBKK	76 Outperform	€82.93M	13.29	13.64%	1.32%	23.97%	833.08%
CBE	74 Outperform	€1.61B	15.36	―	1.36%	10.55%	13.50%
RBT	73 Outperform	€1.61B	17.39	18.22%	1.15%	10.55%	13.50%
AKE	64 Neutral	€3.74B	17.26	2.27%	6.98%	-2.71%	-57.63%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
NK	52 Neutral	€1.77B	-10.59	-5.29%	6.42%	-7.71%	-451.19%
ALCRB	47 Neutral	$122.78M	-3.18	-19.12%	―	90.91%	-22.05%